WebMar 29, 2024 · Ginkgo Bioworks Holdings Inc (DNA:NYQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. ... Ginkgo Bioworks Holdings Inc 27 Drydock Avenue, 8Th Floor BOSTON 02210 United States USA; Phone +1 (310) 209-7280; Fax +1 (302) 655-5049; WebGinkgo Bioworks Holdings Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View DNA financial statements in full.
Ginkgo Bioworks Holdings, Inc. (DNA) - Stock Analysis
Web1 day ago · Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming … Ginkgo Bioworks was founded in 2008 with the mission to make biology easier to … Reshma Shetty co-founded Ginkgo Bioworks in 2008. As President, Chief … Clinical Enterprise, Inc. and Ginkgo Bioworks to Continue Support of Federal … The Organism Company We’re building the leading platform for cell programming. At … Use Ginkgo’s Platform to Create Your Cell Program. Your product is unique and … Announcements Taking Ginkgo Public on NYSE:DNA May 14, 2024; Creative … A New Modality. The successful development of nucleic acid vaccines … Technology Comments on DNA synthesis in Light of Our Deal with Twist November … WebOverview. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables ... chlorprothixen droge
Analysts Predict Ginkgo Bioworks Holdings Inc. (NYSE: DNA) To …
WebApr 8, 2024 · Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Rating) insider Reshma P. Shetty sold 37,650 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $1.22, for a total value of $45,933.00. Following the transaction, the insider now owns 13,767,604 shares of the company's stock, valued at … WebApr 11, 2024 · Company Profile DNA. Business Description. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve … WebGinkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants. The program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airportsBOSTON and NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Ginkgo … gratz borough zoning ordinance